Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy

• Published in: Acta diabetologica Vol. 41; no. 4; pp. 158 - 166
• Main Authors: Misur, I, Zarković, K, Barada, A, Batelja, L, Milicević, Z, Turk, Z
• Format: Journal Article
• Language: English
• Published: Germany Springer Nature B.V 01.12.2004
• Subjects: Aged; Antigen-Antibody Complex - blood; Diabetes; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - immunology; Diabetes Mellitus, Type 2 - metabolism; Diabetes Mellitus, Type 2 - pathology; Diabetic Neuropathies - blood; Diabetic Neuropathies - immunology; Diabetic Neuropathies - metabolism; Diabetic Neuropathies - pathology; Enzyme-Linked Immunosorbent Assay; Female; Femoral Nerve - metabolism; Femoral Nerve - pathology; Fluorescent Antibody Technique; Glycation End Products, Advanced - blood; Glycation End Products, Advanced - immunology; Glycation End Products, Advanced - metabolism; Humans; Male; Medical disorders; Middle Aged; Nervous system; Pathology; Proteins; Sural Nerve - metabolism; Sural Nerve - pathology
• ISSN: 0940-5429; 1432-5233
• DOI: 10.1007/s00592-004-0160-0

Advanced glycation endproducts (AGE) accumulate over proteins as a consequence of diabetic hyperglycemia, and thus contribute to the pathogenesis of diabetic complications. To improve the understanding of the pathology of diabetic neuropathy, AGE accumulation was analyzed in sural and/or femoral nerves obtained under spinal anesthesia from 8 type 2 diabetic patients with both distal symmetrical polyneuropathy and proximal neuropathy. Pronounced AGE immunoreactivity was detected on axons and myelin sheaths in 90% of diabetic peripheral nerves but not in the control specimen. The intensity of axonal AGE immunopositivity significantly correlated with the severity of morphological alterations (p<0.005). AGE localization, demonstrated by immunohistochemical methods, was also present in the endoneurium, perineurium and microvessels. Morphometric analysis of the diabetic peripheral nerve showed perineurial thickening (diabetic vs. control, 15.5+/-4.9 vs. 6.6+/-2.1 microm, p<0.001), narrowing of the microvessel lumina (66.6+/-50.5 vs. 579.5+/-38.4 x10(3) microm(2), p<0.001) and significant reduction in the number of preserved axons (3.6+/-3 vs. 8.9+/-2.3 per 10(5) microm(2) per area, p<0.037). The sera of diabetic patients contained epitope(s) of AGE structure and soluble immune complexes containing AGE moiety. In conclusion, to the best of our knowledge, this is the first study providing evidence for excessive AGE formation on peripheral nerve components, primarily axons, and a significantly higher level of circulating AGE-immune complexes in patients with both distal diabetic polyneuropathy and proximal neuropathy. Humoral immune mechanisms, including the production of anti-AGE autoantibody, may potentially be involved in the development of structural abnormalities described in this report.